PO Box 24076
Victoria, BC Canada
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis in Canada. The company was formerly known as T-Bird Pharma Inc. and changed its name to Emerald Health Therapeutics, Inc. in June 2015. Emerald Health Therapeutics, Inc. is headquartered in Victoria, Canada.
[stock_market_widget type=”chart” symbol=”EMHTF” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
Vision Park Chivers Way Histon
GW Pharmaceuticals plc, a biopharmaceutical company, engages in discovering, developing, and commercializing cannabinoid prescription medicines using botanical extracts derived from the Cannabis plant. The company operates through three segments: Commercial, Sativex Research and Development, and Pipeline Research and Development. Its lead product is Epidiolex, an oral medicine which is in Phase III clinical development for the treatment of refractory childhood epilepsies, as well as for the treatment of Dravet syndrome, Lennox-Gastaut syndrome, tuberous sclerosis complex, and infantile spasms. The company also develops and markets Sativex, an oromucosal spray for the treatment of spasticity due to multiple sclerosis. In addition, it develops various product candidates, which are in Phase I and II clinical development for the treatment of glioma, neonatal hypoxic-ischemic encephalopathy, adult epilepsy, and schizophrenia. Further, the company has license and development agreements with Otsuka Pharmaceutical Co. Ltd.; Almirall S.A.; Bayer HealthCare AG; Ipsen Biopharm Ltd; and Neopharm Group. It primarily operates in Europe, the United States, Canada, and Asia. GW Pharmaceuticals plc was founded in 1998 and is based in Cambridge, the United Kingdom.
[stock_market_widget type=”combo” symbol=”GWPH” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
Kelowna, BC BC Canada
Hiku Brands Company Ltd. focuses on cultivation and sale of medical cannabis in Canada. It also sells coffee, clothing, and curated accessories through a network of retail stores in British Columbia, Alberta, and Ontario. It offers cannabis under the DOJA, Tokyo Smoke, and Van der Pop brands. The company is based in Kelowna, Canada.
[stock_market_widget type=”chart” symbol=”DJACF” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
HONEYSUCKLE is a print and digital publication that emphasizes diverse voices and visual impact. Each quarter, our print edition explores a topical issue through a range of perspectives. Our intimate style of reporting combines input from high-profile celebrities, leaders in various fields, and personal testimony. Online, we expand the conversation in daily posts that include journalism, first-person essays, reviews and poetry. Our cross-generational audience is open, inclusive, and curious, united by their shared passion for knowledge and desire to dive deep into important themes that shape our time.
To date, our print editions have covered topics such as women’s roles and rights, home and homelessness, cannabis as a growing and politically charged industry, and the evolution of sex in our culture. Our covers have featured Oscar nominee Kirsten Dunst, iconic activist actor Alan Cumming, bi-racial model/rapper and homelessness activist Justin Bullock. Major features include Oscar winner Holly Hunter, NFL legend and cannabis advocate/entrepreneur Marvin Washington; Bruce Giffin, acclaimed photojournalist from Detroit, and more. High-quality color printing enables us to refract our topics through photography, painting, and illustration, bringing vibrancy to each page.
National print distribution, inclusion in industry gift bags at events such as New York Fashion Week and SXSW, and a thriving online presence enable HONEYSUCKLE to reach a richly varied audience. Unlike many publications, we do not adapt our material to a given demographic. Rather, we assume that our readers’ interests are broad, and that cross-cultural and cross-generational exchange is vital. In an age of polarity, we seek to soften boundaries and spread information that creates respectful dialogue and action. In as much as human lives are defined by what we care about, we bring that passion to our pages.
Topics we plan to discuss are Sustainability, Quantum Thinking and Social issues.
“Founded by filmmaker Ronit Pinto, Honeysuckle is devoted to expression through all forms of media and offers a unique approach to video storytelling. Through our in-house production company Black Neon Media (staffed by professionals who have worked with Wes Craven, Michael Bay, and Steven Spielberg), as well as collaborations with other dynamic collectives, we produce original content that is at once entertaining, informative, and provocative. In film we aim to push the artistic envelope while composing thoughtful and engaging narratives which center on themes including sexuality, spirituality, violence, activism, and technological innovation.”
Toronto, Ontario, Canada
To achieve Horizons HMMJ’s investment objectives, Horizons HMMJ invests and holds the equity securities of the Constituent Issuers in substantially the same proportion as its Underlying Index. These securities, which could include ADRs, will be listed on stock exchanges in North America, and will be equity securities of life sciences companies, and other companies, with significant business activities in the marijuana industry. Horizons HMMJ’s Underlying Index is ordinarily rebalanced on a quarterly basis at the close of trading on each Rebalancing Date. The Constituent Issuers of its Underlying Index will be market capitalization-weighted on each Rebalancing Date, subject to a cap for each Constituent Issuer of a maximum of 10% of the net asset value of Horizons HMMJ on each Rebalancing Date, with the remainder of the Constituent Issuers’ weights to be increased proportionately.
[stock_market_widget type=”chart” symbol=”HMMJ.TO” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
New York, NY United States
iAnthus Capital Holdings, Inc. engages in the delivery of solutions for financing, developing, and managing state-licensed cannabis cultivators and dispensaries in the United States. The company is headquartered in New York, New York.
[stock_market_widget type=”chart” symbol=”ITHUF” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
Suite 700 PO Box 49290
Vancouver, BC Canada
ICC Labs Inc., through its subsidiaries, produces and sells cannabis in Uruguay. It offers recreational cannabis, medicinal cannabis, cannabinoid extracts, and by-products for medicinal, recreational, and industrial use, as well as industrial hemp. The company is headquartered in Vancouver, Canada.
[stock_market_widget type=”chart” symbol=”ICCLF” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
Vancouver, BC Canada
InMed Pharmaceuticals Inc., a pre-clinical stage biopharmaceutical company, researches and develops novel and cannabinoid-based therapies. The company’s lead product is INM-750, a topical cannabinoid product candidate to treat epidermolysis bullosa (EB). The company is also involved in developing INM-085, a cannabinoid-based topical therapy for glaucoma; and drugs for the treatment of various diseases, including dermatology, ocular, pain, inflammation, cancer, arthritis disease areas, and others. It has an agreement with Pharmaseed Ltd to develop a final formulation for INM-750 targeted as a therapy in EB and other dermatological and wound-healing applications; and a research and development collaboration agreement with ATERA SAS to develop 3D human skin models of EB to evaluate the in vitro drug efficacy of INM-750. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
[stock_market_widget type=”chart” symbol=”IMLFF” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
Chandler, AZ United States
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. It is also developing Cannabidiol Oral Solution, which has completed pediatric study for the treatment of pediatric epilepsy; has completed Phase II study to treat west syndrome; and is in Phase II study for the treatment of childhood absence epilepsy, as well as Buprenorphine Sublingual Spray that has completed Phase III study to treat acute pain. In addition, the company is developing Cannabidiol Oral Solution for the treatment of prader willi; Buprenorphine/Naloxone Sublingual Spray to treat opioid dependence; and Naloxone Nasal Spray for the treatment of opioid antagonist. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona.
[stock_market_widget type=”chart” symbol=”INSY” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]
1800 Newport Circle
Santa Ana, CA 92705
19510 144th Ave NE, Suite A1
Woodinville, WA 98072
3831 Eudora Way
Denver, CO 80207
92705 98072 80207
Kush Bottles, Inc. is a dynamic sales and distribution platform that provides unique products and services for both businesses and consumers in the cannabis industry.
Founded in 2010 as a packaging and supplies company for dispensaries and growers, Kush Bottles has sold more than 1 billion units and now regularly services more than 5,000 legally operated medical and adult-use dispensaries, growers, and producers across North America, South America, and Europe.
The company has facilities in the three largest U.S. cannabis markets and a local sales presence in every major U.S. cannabis market. Kush Bottles aims to be the gold standard for responsible and compliant products and services in the cannabis industry. Kush Bottles has no direct involvement with cannabis plants or extracts.
[stock_market_widget type=”combo” symbol=”KSHB” template=”tablechart” color=”default” fields=”virtual.symbol,virtual.name,quote.regularMarketPrice,quote.regularMarketChange,quote.regularMarketChangePercent” chart=”line” range=”1y” interval=”1mo” line-color=”rgb(49, 125, 189)”]